Radiopharmaceuticals
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
109
NCT05999292
Phase 1 Study of 68Ga-R8760
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 11, 2023
Completion: May 23, 2024
NCT06745804
Study of 68Ga-R10602
Start: Dec 10, 2024
Completion: Mar 31, 2026
NCT07121244
A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer
Start: Oct 1, 2025
Completion: Jun 1, 2033
Loading map...